Abstract: Due to the harms associated with long-term opioid therapy and, often, the lack of benefit, it is guideline concordant to offer patients the opportunity to engage in a …
Abstract: OBJECTIVE: This study aimed to investigate the long-term risk of posttraumatic epilepsy (PTE) and psychogenic nonepileptic seizures (PNES) following mild traumatic brain …
Abstract: This Viewpoint discusses improving US cancer surveillance systems to address veteran-specific risks and outcomes. Veterans shoulder a disproportionate cancer burden due …
Abstract: IMPORTANCE: Acral melanoma (AM), localized to the palms, soles, and nail units, is a unique melanoma subtype less associated with UV radiation. Few studies have evaluated …
Abstract: Objectives: Older U.S. military veterans with cardiovascular disease (CVD) are at elevated risk for functional decline. This study examined sociodemographic, health, and …
Abstract: BACKGROUND: Obstructive sleep apnea (OSA) is common and costly in the U.S. military health system (MHS). OSA is associated with poor health outcomes as well as increased …
Abstract: Pregabalin and duloxetine are widely prescribed non-opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine …
Abstract: From July 2024 through June 2025, a total of 806 members of the active (n=702) and reserve (n=104) components of the U.S. Armed Forces had at least 1 cold weather injury. …
Abstract: Trends in obesity among U.S. active component service members (ACSMs) and civilians are relevant to military recruitment and retention, as excess body weight is a common …
Abstract: Chronic pain affects approximately one-third of active-duty service members (ADSMs), yet effective treatment remains challenging. Salivary cortisol and urinary …
Abstract: OBJECTIVE: To advance patient-centered care for high-need homeless-experienced patients, we identified the rates of various personal health goals, the broader domains …
Abstract: BACKGROUND: Tumor suppressor gene (TSG) alterations prognosticate inferior survival in metastatic hormone-sensitive prostate cancer (mHSPC) and may affect response to …